The 2020 Clinical Dossier: Protected PCI with Impella® is a collection of data and clinical evidence supporting the use of Impella in High-Risk Percutaneous procedures.
Category: Top Downloads
Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study
Using a defined cardiogenic shock best practices protocol derived from real-world data for cardiogenic shock treatment has been associated with improved outcomes. Download this cardiogenic shock guidelines pocket guide, offering best practices derived from the Abiomed Impella® Quality (IQ) Assurance Program and IRB-approved cVAD Study including, minimizing exposure to toxic inotropic medicines, unloading the left … Continue reading “Cardiogenic Shock Protocol Pocket Guide”
The Impella CP is approved for use in high-risk percutaneous coronary intervention and cardiogenic shock and are proven to unload theleft ventricle and support the systemic circulation.¹ Having the opportunity to rest the left ventricle has proven to increase heart recovery while keeping other therapeutic options open. The Impella CP heart pump may provide these … Continue reading “Impella CP® Step-By-Step Left Heart Unloading Poster”
Committed to improving outcomes in Cardiogenic Shock and Protected PCI through excellence in education.
Use this patient transfer checklist and documentation when transferring a patient supported with an Impella® device from the “Spoke” hospital to the “Hub” hospital. Completing the patient transfer checklist ensures the best possible outcome for the patient during the transfer process.
Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) supported with Impella.